Isabelle Debrix
Impact in
- Urology top 10%
- Urinary Bladder and Prostate Research
-
- Colorectal Cancer Treatments and Studies
- Colorectal Cancer Surgical Treatments
Papers in
- Oncology 5
- Cancer Treatment and Pharmacology 3
- Neutropenia and Cancer Infections 2
- Colorectal Cancer Treatments and Studies 2
-
- Health Systems, Economic Evaluations, Quality of Life 4
- Economic and Financial Impacts of Cancer 3
- Co-authors
- Thierry André (5 shared papers)Arnaud Boutan-Laroze (1 shared paper)E. Gamelin (1 shared paper)Marc Buyse (1 shared paper)Emmanuel Quinaux (1 shared paper)Pascal Piedbois (1 shared paper)Emmanuel Achille (1 shared paper)Olivier Bouché (1 shared paper)
- Journals
- Expert Opinion on Pharmacotherapy (1 paper)Clinical Therapeutics (1 paper)Anti-Cancer Drugs (1 paper)Journal of Clinical Oncology (1 paper)Value in Health (1 paper)
- Partner nations
- FranceNew ZealandUnited States
In The Last Decade
Isabelle Debrix
16 papers receiving 245 citations
Peers
Comparison fields: 5 of 59
- Urology 34
- Oncology 83
- Critical Care and Intensive Care Medicine 13
- Rheumatology 27
- Pulmonary and Respiratory Medicine 56
Countries citing papers authored by Isabelle Debrix
This map shows the geographic impact of Isabelle Debrix's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabelle Debrix with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabelle Debrix more than expected).
Fields of papers citing papers by Isabelle Debrix
This network shows the impact of papers produced by Isabelle Debrix. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabelle Debrix. The network helps show where Isabelle Debrix may publish in the future.
Co-authors
The 25 scholars most cited alongside Isabelle Debrix, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 119 | |
| 2 | 2010 | 48 | |
| 3 | Evaluating the differences between fibrin sealants: recommendations from an international advisory panel of hospital pharmacists | 2006 | 27 |
| 4 | 1999 | 25 | |
| 5 | 2013 | 8 | |
| 6 | [Anticancer drugs off label used of: what do the experts think about?]. | 2004 | 7 |
| 7 | 2009 | 5 | |
| 8 | 2001 | 4 | |
| 9 | 2000 | 3 | |
| 10 | 2019 | 2 | |
| 11 | 2016 | 2 | |
| 12 | 1999 | 2 | |
| 13 | [Anticancer drugs use evaluation: limits of the approved labeling]. | 2004 | 2 |
| 14 | 2005 | 1 | |
| 15 | 2008 | 1 | |
| 16 | [Efficacy of the granisetron/solumedrol combination in the control of drug-induced acute nausea and vomiting. Results of a prospective survey]. | 1995 | 1 |
| 17 | 2007 | 0 | |
| 18 | 2021 | 0 | |
| 19 | 2006 | 0 | |
| 20 | 2019 | 0 |
About Isabelle Debrix
Isabelle Debrix is a scholar working on Oncology, Economics and Econometrics, Hematology, Surgery and General Health Professions, having authored 20 papers that have together received 257 indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (4 papers), Cancer Treatment and Pharmacology (3 papers), Economic and Financial Impacts of Cancer (3 papers), Clinical practice guidelines implementation (2 papers), Neutropenia and Cancer Infections (2 papers), Colorectal Cancer Treatments and Studies (2 papers), Sarcoma Diagnosis and Treatment (1 paper) and Multiple and Secondary Primary Cancers (1 paper). The work is most often cited by research in Urology (34 citations), Oncology (83 citations), Critical Care and Intensive Care Medicine (13 citations), Rheumatology (27 citations) and Pulmonary and Respiratory Medicine (56 citations). Isabelle Debrix has collaborated with scholars based in France, New Zealand and United States. Frequent co-authors include Thierry André, Arnaud Boutan-Laroze, E. Gamelin, Marc Buyse, Emmanuel Quinaux, Pascal Piedbois, Emmanuel Achille, Olivier Bouché, N. Tubiana-Mathieu and Aimery de Gramont. Their work appears in journals such as Expert Opinion on Pharmacotherapy, Clinical Therapeutics, Anti-Cancer Drugs, Journal of Clinical Oncology and Value in Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.